Bristol-Myers Squibb Company
BMY
$57.52
$2.133.85%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/20/2026
-
MarketBeat
Bristol-Myers Squibb Advances Japanese Real-World Study of Mavacamten in Hypertrophic Cardiomyopathy
6/26/2026
-
TipRanks
6/26/2026
-
Fool.com Headlines
6/26/2026
-
24/7 Wall St.
6/25/2026
-
MarketBeat
6/25/2026
-
MarketBeat
6/25/2026
-
MarketBeat
6/25/2026
-
Simply Wall St
6/24/2026
-
Globe Newswire
6/24/2026
-
The Cerbat Gem
6/24/2026
-
MarketBeat
6/23/2026
-
Simply Wall St
6/23/2026
-
MarketBeat
6/23/2026
-
MarketBeat
6/22/2026
-
Fool.com Headlines
6/22/2026
-
MarketBeat
6/22/2026
-
MarketBeat
6/21/2026
-
MarketBeat
6/21/2026
-
MarketBeat
6/20/2026
-
MarketBeat
6/20/2026
-
MarketBeat
6/19/2026
-
24/7 Wall St.
6/19/2026
-
24/7 Wall St.
6/19/2026
-
24/7 Wall St.
1/19/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, April 30, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Jul 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
Corporate Info
Website
Phone Number
609 252 4621
Address
Route 206 & Province Line Road
Princeton, NJ 08543
Princeton, NJ 08543
Country
Year Founded
Business Description
Sector
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology...
more